Your browser doesn't support javascript.
The Removal of Airborne Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Other Microbial Bioaerosols by Air Filtration on Coronavirus Disease 2019 (COVID-19) Surge Units.
Conway Morris, Andrew; Sharrocks, Katherine; Bousfield, Rachel; Kermack, Leanne; Maes, Mailis; Higginson, Ellen; Forrest, Sally; Pereira-Dias, Joana; Cormie, Claire; Old, Tim; Brooks, Sophie; Hamed, Islam; Koenig, Alicia; Turner, Andrew; White, Paul; Floto, R Andres; Dougan, Gordon; Gkrania-Klotsas, Effrossyni; Gouliouris, Theodore; Baker, Stephen; Navapurkar, Vilas.
  • Conway Morris A; The John Farman ICU, Cambridge University Hospitals, National Health Service (NHS) Foundation Trust, Cambridge, United Kingdom.
  • Sharrocks K; University Division of Anaesthesia, Department of Medicine, University of Cambridge School of Clinical Medicine, Cambridge Biomedical Campus, Cambridge, United Kingdom.
  • Bousfield R; Department of Infectious Diseases, Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom.
  • Kermack L; Department of Infectious Diseases, Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom.
  • Maes M; Clinical Microbiology Laboratory, Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom.
  • Higginson E; Cambridge Institute of Therapeutic Immunology and Infectious Disease, Department of Medicine, University of Cambridge School of Clinical Medicine, Cambridge Biomedical Campus, Cambridge, United Kingdom.
  • Forrest S; Cambridge Institute of Therapeutic Immunology and Infectious Disease, Department of Medicine, University of Cambridge School of Clinical Medicine, Cambridge Biomedical Campus, Cambridge, United Kingdom.
  • Pereira-Dias J; Cambridge Institute of Therapeutic Immunology and Infectious Disease, Department of Medicine, University of Cambridge School of Clinical Medicine, Cambridge Biomedical Campus, Cambridge, United Kingdom.
  • Cormie C; Cambridge Institute of Therapeutic Immunology and Infectious Disease, Department of Medicine, University of Cambridge School of Clinical Medicine, Cambridge Biomedical Campus, Cambridge, United Kingdom.
  • Old T; Cambridge Institute of Therapeutic Immunology and Infectious Disease, Department of Medicine, University of Cambridge School of Clinical Medicine, Cambridge Biomedical Campus, Cambridge, United Kingdom.
  • Brooks S; Cambridge Institute of Therapeutic Immunology and Infectious Disease, Department of Medicine, University of Cambridge School of Clinical Medicine, Cambridge Biomedical Campus, Cambridge, United Kingdom.
  • Hamed I; Department of Infectious Diseases, Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom.
  • Koenig A; Department of Infectious Diseases, Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom.
  • Turner A; The John Farman ICU, Cambridge University Hospitals, National Health Service (NHS) Foundation Trust, Cambridge, United Kingdom.
  • White P; The John Farman ICU, Cambridge University Hospitals, National Health Service (NHS) Foundation Trust, Cambridge, United Kingdom.
  • Floto RA; Department of Clinical Engineering, Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom.
  • Dougan G; Department of Clinical Engineering, Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom.
  • Gkrania-Klotsas E; Medical Technology Research Centre and School of Medicine, Anglia Ruskin University, Chelmsford, United Kingdom.
  • Gouliouris T; Molecular Immunity Unit, University of Cambridge Department of Medicine, MRC-Laboratory of Molecular Biology, Cambridge, United Kingdom.
  • Baker S; Cambridge Centre for Lung Infection, Royal Papworth Hospital, Cambridge, United Kingdom.
  • Navapurkar V; Cambridge Institute of Therapeutic Immunology and Infectious Disease, Department of Medicine, University of Cambridge School of Clinical Medicine, Cambridge Biomedical Campus, Cambridge, United Kingdom.
Clin Infect Dis ; 75(1): e97-e101, 2022 08 24.
Article in English | MEDLINE | ID: covidwho-2017776
ABSTRACT
Airborne severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was detected in a coronavirus disease 19 (COVID-19) ward before activation of HEPA-air filtration but not during filter operation; SARS-CoV-2 was again detected following filter deactivation. Airborne SARS-CoV-2 was infrequently detected in a COVID-19 intensive care unit. Bioaerosol was also effectively filtered.
Subject(s)
Keywords
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Limits: Humans Language: English Journal: Clin Infect Dis Journal subject: Communicable Diseases Year: 2022 Document Type: Article Affiliation country: Cid

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Limits: Humans Language: English Journal: Clin Infect Dis Journal subject: Communicable Diseases Year: 2022 Document Type: Article Affiliation country: Cid